Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on July 22, 2025
Akari Therapeutics Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
GlobeNewswire
·
July 22, 2025
BOSTON and LONDON, July 22, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) for the treatment of cancer, today announced Abizer …
InStride Health Strengthens Executive Team with Appointment of Chief Commercial Officer and Chief Financial Officer
GlobeNewswire
·
July 22, 2025
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- InStride Health, a leading insurance-based provider of specialty anxiety and obsessive-compulsive disorder (OCD) treatment for children, adolescents and young adults, today announced the appointment of Don LeBlanc …
Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales
GlobeNewswire
·
July 22, 2025
HINGHAM, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced the appointment of Christina Bailey as its new Vice President of Sales. A two-time U.S. …
HYCU® Positioned as a Visionary in the 2025 Gartner® Magic Quadrant™ for Backup and Data Protection Platforms for Fourth Consecutive Year
GlobeNewswire
·
July 22, 2025
Boston, Massachusetts, July 22, 2025 (GLOBE NEWSWIRE) -- HYCU, Inc., a leader for modern data protection for on-prem, cloud, and SaaS and one of the fastest growing companies in the industry, today announced that it has been named a Visionary in the 2025 …
Duck Creek Earns Five Celent XCelent Awards for Excellence in Insurance Technology
GlobeNewswire
·
July 22, 2025
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies, the global provider defining the future of property and casualty (P…
uniQure to Announce Second Quarter 2025 Financial Results
GlobeNewswire
·
July 22, 2025
LEXINGTON, Mass. and AMSTERDAM, July 22, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report second quarter 2025 financial results before …
Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025
GlobeNewswire
·
July 22, 2025
CAMBRIDGE, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio webcast on August 6, 2025 at 8:30 a.m. ET to …
Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025
GlobeNewswire
·
July 22, 2025
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that it will report second quarter 2025 financial results on August 5, 2025, before the open of the U.S. financial markets. The company does not intend to …
Avalyn Completes Oversubscribed $100 Million Series D Financing to Further Advance Clinical Development of Novel Inhaled Therapies for Pulmonary Fibrosis
GlobeNewswire
·
July 22, 2025
Financing led by Suvretta Capital Management and SR One with participation from 16 additional healthcare investors Proceeds will support key clinical milestones across all of Avalyn’s pipeline programs CAMBRIDGE, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- …
Morphoceuticals Announces Roger Pomerantz, MD, as Chairman of its Board of Directors
GlobeNewswire
·
July 22, 2025
MEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Morphoceuticals Inc., a TechBio company pioneering AI-guided electroceuticals for tissue repair and organ regeneration, today announced the appointment of industry veteran Roger Pomerantz, MD, as Chairman …
Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences
GlobeNewswire
·
July 22, 2025
BEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming scientific conferences in July …
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
GlobeNewswire
·
July 22, 2025
BEDFORD, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), today announced the successful completion of its previously disclosed acquisition of Life Molecular Imaging Ltd. ("Life Molecular"), a …
Seres Therapeutics Announces Leadership Transition
GlobeNewswire
·
July 22, 2025
Thomas DesRosier and Marella Thorell, accomplished biopharma executives, appointed co-CEOs; Eric Shaff stepping down as CEO and will remain a Director on the Seres Board Seres engaging with multiple parties regarding various deal structures, including …
Replimune Receives Complete Response Letter from FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
GlobeNewswire
·
July 22, 2025
WOBURN, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) …
Progress Software Announces Amended Credit Facility
GlobeNewswire
·
July 22, 2025
New $1.5B facility will support continued growth and provide greater scale and flexibility BURLINGTON, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Progress Software (Nasdaq: PRGS), the trusted provider of AI-powered digital experience and infrastructure …
Life Biosciences Announces Research Collaboration with SingHealth Duke-NUS Regenerative Medicine Institute of Singapore (REMEDIS) to Expand Pipeline of Cellular Rejuvenation Therapies
GlobeNewswire
·
July 22, 2025
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- – Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation therapies to reverse and prevent multiple diseases of aging, today announced the signing of a Memorandum of Understanding ( …